Phibro Animal Health Corp (NASDAQ:PAHC)’s share price reached a new 52-week high and low during trading on Friday . The company traded as low as $41.65 and last traded at $41.55, with a volume of 110954 shares trading hands. The stock had previously closed at $40.55.
A number of equities analysts have recently commented on the stock. BidaskClub raised shares of Phibro Animal Health from a “strong sell” rating to a “sell” rating in a research report on Saturday, January 6th. Credit Suisse Group lifted their price target on shares of Phibro Animal Health from $37.00 to $39.00 and gave the company a “neutral” rating in a research report on Tuesday, February 6th. Morgan Stanley lifted their price target on shares of Phibro Animal Health from $30.00 to $36.00 and gave the company an “underweight” rating in a research report on Wednesday, February 7th. Zacks Investment Research raised shares of Phibro Animal Health from a “sell” rating to a “hold” rating in a research report on Monday, January 8th. Finally, ValuEngine raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Wednesday, February 28th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $38.20.
The stock has a market cap of $1,607.64, a P/E ratio of 25.32, a P/E/G ratio of 2.84 and a beta of 0.93. The company has a current ratio of 3.12, a quick ratio of 1.75 and a debt-to-equity ratio of 1.82.
The business also recently announced a quarterly dividend, which was paid on Wednesday, March 28th. Investors of record on Wednesday, March 7th were given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 0.96%. The ex-dividend date was Tuesday, March 6th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 26.49%.
In related news, COO Larry Lee Miller sold 54,572 shares of the business’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $35.36, for a total transaction of $1,929,665.92. Following the transaction, the chief operating officer now owns 8,582 shares of the company’s stock, valued at $303,459.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jack Bendheim sold 24,000 shares of the business’s stock in a transaction on Thursday, March 15th. The stock was sold at an average price of $40.05, for a total transaction of $961,200.00. The disclosure for this sale can be found here. Insiders have sold 276,056 shares of company stock worth $10,495,260 in the last ninety days. 51.88% of the stock is currently owned by insiders.
A number of hedge funds have recently made changes to their positions in the stock. Copper Rock Capital Partners LLC increased its position in Phibro Animal Health by 9.6% during the fourth quarter. Copper Rock Capital Partners LLC now owns 631,876 shares of the company’s stock worth $21,326,000 after acquiring an additional 55,235 shares during the period. Goldman Sachs Group Inc. boosted its stake in Phibro Animal Health by 17.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 476,391 shares of the company’s stock worth $15,959,000 after buying an additional 69,063 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Phibro Animal Health by 11.8% during the third quarter. Dimensional Fund Advisors LP now owns 465,297 shares of the company’s stock worth $17,239,000 after buying an additional 49,296 shares in the last quarter. Renaissance Technologies LLC boosted its stake in Phibro Animal Health by 16.4% during the fourth quarter. Renaissance Technologies LLC now owns 463,496 shares of the company’s stock worth $15,527,000 after buying an additional 65,396 shares in the last quarter. Finally, Ameriprise Financial Inc. boosted its stake in Phibro Animal Health by 26.7% during the third quarter. Ameriprise Financial Inc. now owns 430,656 shares of the company’s stock worth $15,958,000 after buying an additional 90,660 shares in the last quarter. 48.07% of the stock is currently owned by institutional investors and hedge funds.
WARNING: “Phibro Animal Health (PAHC) Reaches New 12-Month High and Low at $41.65” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.tickerreport.com/banking-finance/3336172/phibro-animal-health-pahc-reaches-new-12-month-high-and-low-at-41-65.html.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.